marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Allogene Therapeutics Cash Flow 2011-2024 | ALLO
Annual Cash Flow Allogene Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-238 M | -221 M | -185 M | -115 M | -137 M | -44.7 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
14.2 M | 14.3 M | 10.5 M | 7.4 M | 4.6 M | 1 M | - | - | - | - | - | - | - |
Accounts Payables |
5.9 M | 13.9 M | 10.3 M | 10.4 M | 9.25 M | 12.3 M | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Allogene Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -55.9 M | - | - | - | -66.6 M | - | -158 M | -111 M | -68.2 M | - | -139 M | -90.5 M | -49.3 M | - | -105 M | -67.5 M | -40.8 M | - | -87.1 M | -55.1 M | -30.3 M | - | -23.2 M | -6.04 M | 5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 3.56 M | - | - | - | 3.51 M | - | 11.2 M | 7.37 M | 3.69 M | - | 6.21 M | 3.88 M | 1.92 M | - | 5.59 M | 3.78 M | 1.89 M | - | 2.72 M | 1.54 M | 544 K | - | 651 K | 299 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
5.51 M | 12.9 M | 5.78 M | 5.9 M | 6.2 M | 10.2 M | 14.7 M | 13.9 M | 11 M | 9.71 M | 8.71 M | 10.3 M | 11.5 M | 11 M | 14.9 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 9.25 M | 9.25 M | 9.25 M | 9.25 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency